Effects of a 5‐HT3 antagonist, ondansetron, on fasting and postprandial small bowel water content assessed by magnetic resonance imaging
Open Access
- 1 August 2010
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 32 (5) , 655-663
Abstract
Aliment Pharmacol Ther 2010; 32: 655–663 Summary Background 5‐HT3 antagonists have been shown to be effective in relieving the symptoms of irritable bowel syndrome with diarrhoea (IBS‐D). Using a recently validated magnetic resonance imaging (MRI) method, we have demonstrated reduced fasting small bowel water content (SBWC) in IBS‐D associated with accelerated small bowel transit. We hypothesized that slowing of transit with ondansetron would lead to an increase in SBWC by inhibiting fasting motility. Aim To assess the effects of ondansetron compared with placebo in healthy volunteers on SBWC and motility in two different groups of subjects, one studied using MRI and another using manometry. Methods Healthy volunteers were given either a placebo or ondansetron on the day prior to and on the study day. Sixteen volunteers underwent baseline fasting and postprandial MRI scans for 270 min. In a second study, a separate group of n = 18 volunteers were intubated and overnight migrating motor complex (MMC) recorded. Baseline MRI scans were carried out after the tube was removed. Results Fasting SBWC was markedly increased by ondansetron (P < 0.0007). Ondansetron reduced the overall antroduodenal Motility Index (P < 0.04). The subjects who were intubated had significantly lower fasting SBWC (P < 0.0002) compared with the group of subjects who were not intubated. Conclusions The 5‐HT3 receptor antagonism increased fasting small bowel water. This was associated with reduced fasting antroduodenal Motility Index which may explain the clinical benefit of such drugs.Keywords
This publication has 45 references indexed in Scilit:
- Effects of 5-Hydroxytryptamine (Serotonin) Type 3 Antagonists on Symptom Relief and Constipation in Nonconstipated Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsClinical Gastroenterology and Hepatology, 2008
- Non-invasive quantification of small bowel water content by MRI: a validation studyPhysics in Medicine & Biology, 2007
- Luminally released serotonin stimulates colonic motility and accelerates colonic transit in ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI DisordersGastroenterology, 2007
- 5-HT induces duodenal mucosal bicarbonate secretion via cAMP- and Ca2+-dependent signaling pathways and 5-HT4 receptors in miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- 5‐HT activates neural reflexes regulating secretion in the guinea‐pig colonNeurogastroenterology & Motility, 1997
- 5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake.Gut, 1994
- Reduction of rectal sensitivity and post‐prandial motility by granisetron, a 5 HT3‐receptor antagonist, in patients with irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 1993
- Antroduodenal manometryDigestive Diseases and Sciences, 1992
- Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5‐hydroxytryptamine receptor (type 3) antagonistAlimentary Pharmacology & Therapeutics, 1990